HealthEquity, Inc (HQY) PT Lowered to $81 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts HQY Hot Sheet
Price: $102.03 --0%
Rating Summary:
22 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Rating Summary:
22 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Join SI Premium – FREE
JPMorgan analyst Anne Samuel lowered the price target on HealthEquity, Inc (NASDAQ: HQY) to $81.00 (from $84.00) while maintaining a Overweight rating.
You May Also Be Interested In
- HealthEquity Schedules Third Quarter Earnings Release Date
- Rhythm Pharmaceuticals (RYTM) PT Raised to $166 at Citizens on Favorable Setup
- CRISPR Therapeutics (CRSP) PT Lowered to $70 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
